Proton spectroscopy of the neonatal brain following hypoxic-ischaemic injury
Related Experiment Videos
C J Peden1, M A Rutherford, J Sargentoni
1NMR Unit, Royal Postgraduate Medical School, London.
Insights
Proton magnetic resonance spectroscopy revealed biochemical brain changes in infants with hypoxic-ischaemic encephalopathy (HIE). Early spectroscopy findings may predict neurodevelopmental outcomes by one year.
Area of Science:
- Neuroscience
- Biochemistry
- Pediatric Neurology
Background:
- Hypoxic-ischaemic encephalopathy (HIE) is a serious birth complication affecting newborns.
- Early detection and outcome prediction in HIE are crucial for timely intervention.
- Proton magnetic resonance spectroscopy (MRS) offers a non-invasive method to assess brain biochemistry.
Purpose of the Study:
- To investigate the utility of proton MRS in characterizing brain biochemistry in term infants with HIE within the first month of life.
- To correlate early MRS findings with neurodevelopmental outcomes at one year of age.
Main Methods:
- Proton magnetic resonance spectroscopy (MRS) was performed on 11 term infants (10 with HIE, 1 control) within the first month of life.
- Analysis focused on peak resonances assigned to N-acetyl-aspartase (NAA), choline-containing compounds (Cho), and creatine/phosphocreatine (Cr).
- Spectroscopic ratios (NAA/Cho, NAA/Cr) were calculated and correlated with one-year neurodevelopmental outcomes.
Main Results:
- All infants showed detectable NAA, Cho, and Cr resonances.
- The ratios of NAA/Cho and NAA/Cr in the initial MRS scans correlated significantly with the neurodevelopmental outcomes observed at one year.
- These findings indicate distinct biochemical profiles associated with HIE.
Conclusions:
- Proton magnetic resonance spectroscopy (MRS) provides valuable insights into the biochemical alterations in the brains of infants with HIE.
- Early proton MRS may serve as a predictive tool for neurodevelopmental outcomes in HIE infants within the first month of life.
- This non-invasive technique enhances our understanding and management of HIE.
Abstract:
Proton magnetic resonance spectroscopy was used to examine, within the first month of life, the brains of 11 infants born at term--10 with signs of hypoxic-ischaemic encephalopathy (HIE) and one who was neurologically normal at birth. All the infants had peak resonances on their spectra which could be assigned to N-acetyl-aspartase (NAA), choline-containing compounds (Cho) and creatine plus phosphocreatine (Cr). When neurodevelopmental outcome at one year was correlated with initial spectroscopy findings, the NAA/Cho and NAA/Cr ratios reflected clinical outcome. This study suggests that proton spectroscopy not only provides new information about biochemical changes occurring in the brains of infants with HIE, but also may help to predict outcome within the first month of life.